Browse resources

Total results with these characteristics: 1321

Effectively Introducing a New Meningococcal A Conjugate Vaccine in Africa: The Burkina Faso Experience

In 2010, Burkina Faso conducted a country-wide campaign to introduce a new Group A meningococcal conjugate vaccine, MenAfriVac™. Leading up to this effort, the following challenges were successfully managed: (1) conducting a large safety study …

Author: Djingarey MH, Barry R, Bonkoungou M, et al.

Published: 2012

Effectiveness of Haemophilus influenzae type b Conjugate Vaccine on Prevention of Pneumonia and Meningitis in Bangladeshi Children: A Case-Control Study

Few Asian countries have introduced Haemophilus influenzae type b (Hib) conjugate vaccine because of its cost and uncertainty regarding disease burden. To estimate the effectiveness of Hib conjugate vaccine in preventing pneumonia and meningitis in …

Author: Baqui AH, El Arifeen S, Saha SK, et al.

Published: 2007

Effectiveness of Maternal Influenza Immunization in Mothers and Infants

Young infants and pregnant women are at increased risk for serious consequences of influenza infection. Inactivated influenza vaccine is recommended for pregnant women but is not licensed for infants younger than six months of age. This study …

Author: Zaman K, Roy E, Arifeen S, et al.

Published: 2008

Effectiveness of One Dose of SA 14-14-2 Vaccine Against Japanese Encephalitis

Correspondence, published in the New England Journal of Medicine, about a small case control study in Uttar Pradesh, India, on the efficacy of a single dose of the SA 14-14-2 JE vaccine within six months of its administration. …

Author: Kumar R, Tripathi P, Rizvi A

Published: 2009

Effects of Freezing on Vaccine Potency: Literature Review

This document provides a literature review of articles about the effects of freezing on vaccine potency of hepatitis B, tetanus toxoid, diphtheria, and pertussis vaccines. Also included is a review of stability data of …

Author: PATH

Published: 2003

Efficacy of a Pneumococcal Conjugate Vaccine Against Acute Otitis Media

This study, published in the New England Journal of Medicine, enrolled 1662 infants in a randomized, double-blind efficacy trial of a heptavalent pneumococcal polysaccharide conjugate vaccine in which the carrier protein is the nontoxic …

Author: Eskola J, Kilpi T, Palmu A, et al.

Published: 2001

Efficacy of Human Rotavirus Vaccine Against Rotavirus Gastroenteritis During the First 2 Years of Life in European Infants: Randomised, Double-Blind Controlled Study

This article, published in The Lancet, presents data that show high efficacy for GSK's Rotarix® administered with routine vaccines. Over two seasons, Rotarix® demonstrated 90 percent efficacy against severe rotavirus among European …

Author: Vesikari T, Karvonen A, Prymula R, et al.

Published: 2007

Efficacy of Nine-valent Pneumococcal Conjugate Vaccine Against Pneumonia and Invasive Pneumococcal Disease in The Gambia: Randomized Double-Blind, Placebo-Controlled Trial

Published in The Lancet, this study aims to assess the efficacy of a nine-valent pneumococcal conjugate vaccine in children through a randomised, placebo-controlled, double-blind trial in eastern Gambia. Children age 6–51 weeks were randomly …

Author: Cutts U, Zaman SMA, Enwere G, et al.

Published: 2005

Efficacy of Pentavalent Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Infants in Developing Countries in Asia: A Randomised, Double-Blind, Placebo-Controlled Trial

This article, published in The Lancet, assesses the clinical efficacy of the pentavalent, live oral rotavirus vaccine for the prevention of severe rotavirus gastroenteritis in infants in Bangladesh and Vietnam. Study results demonstrated vaccine …

Author: Zaman K, Dang DA, Victor JC, et al.

Published: 2010

Efficacy of Pentavalent Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Infants in Developing Countries in Sub-Saharan Africa: A Randomised, Double-Blind, Placebo-Controlled Trial

This article, published in The Lancet, shares results of an efficacy study of the pentavalent, live oral rotavirus vaccine in Ghana, Kenya, and Mali. Results showed 39.3 percent efficacy against  severe rotavirus gastroenteritis. The authors …

Author: Armah GE, Sow SO, Breiman RF, et al.

Published: 2010

Efficacy of Pneumococcal Conjugate Vaccines and Their Effort on Carriage and Antimicrobial Resistance

Pneumococcal conjugate vaccines have shown a high degree of success in preventing pneumococcal bacteraemia in children. They also reduce the acquisition of carriage of vaccine serotypes in the nasopharynx, and reduce otitis media caused by those …

Author: Klugman K

Published: 2001

Efficacy of RTS,S/AS01E Vaccine Against Malaria in Children 5 to 17 Months of Age

This study, published in the New England Journal of Medicine, evaluated the efficacy of the RTS,S malaria vaccine given with a more immunogenic adjuvant system (AS01E) than one used in a previous study (AS02A). The study was conducted in …

Author: Bejon P, Lusingu J, Olotu A, et al.

Published: 2008

Efficacy of the Human Rotavirus Vaccine RIX4414 in Malnourished Children

This study, published in the Journal of Infectious Diseases, determined that the Rotarix® vaccine produced by GlaxoSmithKline decreased the incidence severe gastroenteritis caused by rotavirus at comparable rates among well-nourished and …

Author: Perez-Schael I, Salinas B, Tomat M, et al.

Published: 2007

Eliminating Epidemic Group A Meningococcal Meningitis in Africa Through a New Vaccine

This article, published in Health Affairs, discusses a new affordable vaccine against Group A meningococcus, the most common cause of large and often fatal African epidemics of meningitis, that was introduced in Burkina Faso, Mali, and Niger in …

Author: LaForce FM, Okwo-Bele J-M

Published: 2011

Elimination of Haemophilus influenzae type b (Hib) Disease From The Gambia After the Introduction of Routine Immunisation With a Hib Conjugate Vaccine: A Prospective Study

Routine immunization of infants in The Gambia with a Haemophilus influenzae type b (Hib) polysaccharide-tetanus toxoid conjugate vaccine began in May 1997. This article, published in The Lancet, reports on a study that investigated the effectiveness …

Author: Adegbola RA, Secka O, Lahai G, et al.

Published: 2005

E-medicine: Japanese Encephalitis

This article provides a comprehensive overview of the disease.

Author: Kallen A

Published: 2002

Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans

This article, published in the New England Journal of Medicine, describes the findings of the US Centers for Disease Control and Prevention's Novel Swine-Origin Influenza A(H1N1) Virus Investigation Team from their assessment of the …

Author: Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team

Published: 2009

Emergence of G12 Rotavirus Strains in Delhi, India, in 2000 to 2007

In this article, published in the Journal of Clinical Microbiology, researchers identified a broad diversity of rotavirus strains among children in India, including several unusual strains and two novel strains. The study highlights the great …

Author: Sharma S, Ray P, Gentsch JR, Glass RI, Kalra V, Bhan MK

Published: 2008

Emergency or Routine Vaccination Against Meningococcal Disease in Africa?

This comment, published in The Lancet, is based on a review of the study "Emergency Vaccination Against Epidemic Meningitis in Ghana: Implications for the Control of Meningococcal Disease in West Africa." The author concludes that …

Author: Peltola H

Published: 2000

Emergency Vaccination Against Epidemic Meningitis in Ghana: Implications for the Control of Meningococcal Disease in West Africa

This article, published in The Lancet, assessed the potential effects of different vaccination strategies against meningococcal disease using data from the 1997 meningococcal outbreak in northern Ghana. Using a simple mathematical model, …

Author: Woods CW, Armstrong G, Sackey SO, et al.

Published: 2000

The Emerging Adolescent Agenda: HPV Vaccine, AIDS Prevention Research, and the New Opportunities for Reaching the Young People of the World

This chapter from an annual report explores why licensure of the vaccine against human papillomavirus (HPV) presents the AIDS vaccine field with new opportunities. The report discusses how to advocate for financing commitments to ensure widespread …

Author: AIDS Vaccine Advocacy Coalition

Published: 2006

Enhanced Pulmonary Histopathology is Observed in Cotton Rats Immunized with Formalin-Inactivated Respiratory Syncytial Virus (RSV) or Purified F Glycoprotein and Challenged With RSV 3-6 Months After Immunization

The authors of this study, published in Vaccine, compared formalin-inactivated (FI) RSV, purified F glycoprotein in alum, and RSV infection (intranasal) for their immunogenicity, efficacy, and ability to enhance pulmonary histopathology during RSV …

Author: Murphy BR, Sotnikov AV, Lawrence LA, Banks SM, Prince GA

Published: 1990

Ensuring Access to HPV Vaccines Through Integrated Services: A Reproductive Health Perspective

This article, published in the Bulletin of the World Health Organization, describes avenues for service delivery of human papillomavirus (HPV) vaccines and critical information gaps that must be bridged in order to inform future sexual and …

Author: Pollack AE, Balkin M, Edouard L, Cutts F, and Broutet N on behalf of the WHO/United Nations Population Fund Working Group on Sexual and Reproductive Health and HPV Vaccines

Published: 2007

Ensuring That Developing Countries Have Access to New Healthcare Products: The Role of Product Development Partnerships

According to this article published in the eJournal Innovation Strategies Today, product development partnerships (PDPs) are generating an increasing flow of health products, including vaccines, for diseases prevalent in developing countries. …

Author: Brooks AD, Wells WA, McLean TD, et al.

Published: 2010

Enteric Diseases

This web page provides information in enteric diseases, including NIAID-supported research, meeting summaries, news releases, and resources for researchers.

Author: US National Institute for Allergy and Infectious Diseases (NIAID)